Singapore markets closed

The Cigna Group (CI)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
341.50-3.00 (-0.87%)
At close: 04:00PM EDT
339.00 -2.50 (-0.73%)
After hours: 06:26PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close344.50
Open342.29
Bid339.31 x 1400
Ask341.60 x 800
Day's range334.71 - 343.65
52-week range240.50 - 365.71
Volume2,405,824
Avg. volume1,483,354
Market cap97.011B
Beta (5Y monthly)0.58
PE ratio (TTM)19.64
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yield5.60 (1.57%)
Ex-dividend date04 Jun 2024
1y target estN/A
  • PR Newswire

    The Cigna Group Reports Strong First Quarter 2024 Results, Raises 2024 Outlook

    Global health company The Cigna Group (NYSE: CI) today reported strong first quarter 2024 results reflecting growth across its diversified portfolio of businesses.

  • PR Newswire

    New Report: Employers Play Critical Role in Curbing Today's Youth Mental Health Crisis

    Many American children struggling with mental health challenges do not receive optimal care, and it's exacerbating the damaging ripple effect on working parents and their employers, according to global health company The Cigna Group (NYSE: CI). A new report by the Evernorth Research Institute details the increasing significance of the youth mental health crisis, the challenges parents face, and provides a roadmap of specific steps employers can take to better support today's workforce.

  • PR Newswire

    Evernorth announces Humira biosimilar available at $0 out of pocket for Accredo patients in June

    In an important step toward driving long-term affordability and access to treatments for chronic and complex conditions, Evernorth Health Services announced that it will have a Humira® biosimilar available for $0 out of pocket for eligible patients of its specialty pharmacy Accredo beginning this June. The high- and low-concentration interchangeable biosimilar will be produced for Evernorth's affiliate private label pharmaceutical distributor, Quallent Pharmaceuticals, through agreements with mu